Genenta Science SPANASDAQ:GNTA
- LAST PRICE3.6500
- TODAY'S CHANGE (%)0.0200 (0.5510%)
- Bid / Lots3.6500/ 30
- Ask / Lots4.0000/ 21
- Open / Previous Close3.6500 / 3.6300
- Day Range
- 52 Week Range
- Volume238
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GNTA |
|---|---|---|
| 09:32 ET | 181 | 3.65 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Genenta Science SPA | 66.1M | -5.3x | --- |
AN2 Therapeutics Inc | 70.6M | -0.9x | --- |
Anebulo Pharmaceuticals Inc | 70.3M | -6.4x | --- |
Instil Bio Inc | 69.9M | -0.4x | --- |
Landos Biopharma Inc | 69.1M | -6.4x | --- |
enVVeno Medical Corp | 73.2M | -2.8x | --- |
Company Information
Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.
Contact Information
- Headquarters
- Via Olgettina 58MILANO, Italy 20132
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Executive Scientific Board
- Luigi Naldini
- Independent Chairman of the Board
- Stephen Squinto
- Chief Executive Officer, Vice Chairman of the Board, General Manager
- Pierluigi Paracchi
- Chief Financial Officer
- Richard Slansky
- Scientific Project Manager and Communication Officer
- Stefania Mazzoleni
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $66.1M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 18.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.68 |
Book Value | $1.20 |
P/E Ratio | -5.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
